Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: Characterization and diagnostic utility

Blood

Volumn 89, Issue 8, 1997, Pages 2909-2914

  Sang, Bi Ching ^b   Shi, Liangru ^b   Dias, Peter ^b   Liu, Li ^b   Wei, Jia ^b   Wang, Zhi Xue ^b   Monell, Craig R ^b   Behm, Fred ^b   Gruenwald, Stefan ^a  

^a BD Technologies   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 19; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031000905     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2909     Document Type: Article

References (22)

1. Kamps MP, Murre C, Sun X-H, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1; 19) translocation protein in pre-B ALL. Cell 60:547, 1990
2. Nourse J, Mellentin JD, Galili N, Wikinson J, Stanbridge E, Smith SD, Cleary ML: Chromosomal translocation t(1; 19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535, 1990
3. Carroll AJ, Crist W, Parmley R, Roper M, Cooper M, Finley W: Pre-B leukemia associated with chromosome translocation 1; 19. Blood 63:761, 1984
4. Williams D, Look AT, Melvin S, Roberson P, Dahl G, Flake T, Stras S: New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell 36:101, 1984
5. Ohno H, Inoue T, Akasaka T, Okumura A, Miyanishi S, Ohashi I, Kikuchi M, Masuya M, Amano H, Imanaka T: Acute lymphoblastic leukemia associated with a t(1; 19) (q23;p13) in an adult. Intern Med 32:584, 1993
6. Hanthorn P, Kiledjian M, Kadesch T: Two distinct transcription factors that bind the immunoglobulin enhancer mE5/kE2 motif. Science 247:467, 1990
7. Nelson C, Shen L, Meister A, Fodor E, Rutter WJ: Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev 4:1035, 1990
8. Kadesch T: Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today 13:31, 1992
9. Hu J, Olson EN, Kingston RE: HEB, a helix-loop-helix protein related to E2A and ITF-2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol 12:1031, 1992
10. Murre C, Bain G, VanDijk MA, Engel I, Furnari A, Massari JR, Matthews MW, Quong MW, Rivera RR, Stuiver MH: Structure and function of helix-lopp-helix protein. Biochim Biophys Acta 1218:129, 1994
11. Bain G, Gruenwald S, Murre C: E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol 13:3522, 1993
12. VanDijk MA, Voorhoove PM, Murre C: Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 90:6061, 1993
13. Lebrun D, Cleary ML: Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1; 19) leukemias. Oncogene 9:1641, 1994
14. Lu Q, Knoepfler PS, Scheeler J, Wright DD, Kamps MP: Both pbx1 and E2A pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogens. Mol Cell Biol 15:3786, 1995
15. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary M: Transcription properties of the E2a-pbx1 chimeric oncoprotein: fusion with E2a is essential, but the pbx1 homeodomain is dispensable. Mol Cell Biol 14:8304, 1994
16. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML: The t(1;19) (q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemia. Blood 77:687, 1991
17. Izraeli S, Kovar H, Gadner H, Lion T: Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood 80:1413, 1992
18. Guan KL, Dixon JE: Eukaryotic proteins expressed in Escherichia call: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione s-transferase. Anal Biochem 192:262, 1991
19. Kamps MP, Look AT, Baltimore D: The human t(1; 19) translocation in pre-B ALL produces multiple nuclear E2A-pbx1 fusion proteins with differing transforming potentials. Genes Dev 5:358, 1991
20. Jacobs Y, Vierra C, Nelson C: E2A expression, nuclear localization, and in vivo formation of DNA- and non DNA-binding species during B-cell development. Mol Cell Biol 13:7321, 1993
21. Numata S-I Kato K, Horibe K: New E2A/PBX1 fusion transcript in a patient with t(1; 19) (q23;p13) acute lymphoblastic leukemia. Leukemia 7:1441, 1993
22. Privitera E, Luciano A, Ronchetti D, Arico M, Santostasi T, Basso G, Biondi A: Molecular variants of the 1; 19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 8:554, 1994